Discover 2,440 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,440
Same-Day Discharge After Nipple-sparing Mastectomy or Skin-sparing Mastectomy With Breast Reconstruction
for
Breast Cancer, Mastectomy; Lymphedema, Same Day Surgery,
Location: Baltimore MD, Washington DC
Sponsor: Georgetown University
Sex: Female
Age: 18+
Code: NCT04596683
Recruiting
Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
for
Advanced Clear Cell Renal Carcinoma (Ccrcc),
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05665361
Phase 1, Phase 2, Recruiting
Stargardt-like Macular Dystrophy (STDG3) Secondary to Mutations in ELOVL4
for
Stargardt-Like Macular Dystrophy
Location: Bethesda MD
Sponsor: National Eye Institute (NEI)
Sex: All
Age: 10 - 70+
Code: NCT04591483
Recruiting
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
for
Lung Neoplasm
Location: Boston MA, Baltimore MD, Durham NC, Miami FL,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT02984761
Recruiting
Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas
for
Neurofibromatosis 1
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT04750928
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
for
Germ Cell Tumor
Location: Boston MA, New York NY, Baltimore MD, Columbus OH,
Sponsor: University of Sydney
Sex: All
Age: 11 - 50
Code: NCT02582697
Phase 3, Recruiting
Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea
for
Obesity, Diabetes, Obstructive Sleep Apnea
Location: Bethesda MD
Sponsor: Mid-Atlantic Epilepsy and Sleep Center, LLC
Sex: All
Age: 18 - 70
Code: NCT02069197
Phase 2, Recruiting
ShuntCheck-Micro-Pumper Pediatric Clinical Outcomes Study
for
Suspected CSF Shunt Obstruction
Location: Boston MA, Providence RI, Stony Brook NY,
Sponsor: NeuroDx Development
Sex: All
Age: 2 - 29
Code: NCT01881711
Recruiting
Study to Evaluate Tetanizing Burst Therapy in Patients Undergoing ICD Replacement
for
Cardiac Electrophysiology
Location: Baltimore MD
Sponsor: EP Sciences
Sex: All
Age: 18 - 70+
Code: NCT03628911
Recruiting
Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis
for
Chronic Pancreatitis, Chronic Pain
Location: Baltimore MD, Pittsburgh PA, Indianapolis IN
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT04996628
Recruiting
Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
for
Severe Aplastic Anemia, Telomere Biology Disorders,
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: All
Age: 2 - 70+
Code: NCT05012111
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for
cGVHD
Location: Boston MA, New York NY, New Brunswick NJ, Baltimore MD,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT05919511
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
for
Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Location: Shirley NY, Hackensack NJ, New Brunswick NJ,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT06423911
Phase 3, Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: Portland ME, Waterbury CT, Mineola NY, Mount Kisco NY,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Location: Bethesda MD, Orange City FL, Toledo OH, Grand Rapids MI,
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Sex: All
Age: 18+
Code: NCT06095583
Phase 3, Recruiting
Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: New Haven CT, Brooklyn NY, New York NY, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06350097
Phase 3, Recruiting
Hyperbaric Oxygen Brain Injury Treatment Trial
for
Traumatic Brain Injury
Location: Baltimore MD, Durham NC, West Palm Beach FL, Detroit MI,
Sponsor: Gaylan Rockswold
Sex: All
Age: 16 - 65
Code: NCT02407028
Phase 2, Recruiting
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
for
Hearing Loss, Head and Neck Cancer
Location: Baltimore MD, Bethesda MD, Fairfax VA, Rochester NY,
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)